IPOGrid
Gratis y legible. Basado en filings, términos de deal, pistas de bolsa, ventanas de timing y señales curadas de compañías.
| Compañía | Deal | Estado | Señal | Precio | Ingresos brutos | Banco líder | Bolsa | Último formulario | Último filing |
|---|---|---|---|---|---|---|---|---|---|
| ipo | amended | - | $10.00 | $200,000,000 | self-underwritten | NYSE | S-1/A | 2026-06-24 | |
| ipo | amended | - | $0.02 | $101,250 | self-underwritten | - | S-1/A | 2026-06-23 | |
| follow-on | amended | - | - | - | - | NYSE | S-4/A | 2026-06-22 | |
| ipo | amended | - | - | - | self-underwritten | NYSE Arca | S-1/A | 2026-06-18 | |
| ipo | amended | - | - | - | - | NYSE Arca | S-1/A | 2026-06-18 | |
| ipo | amended | - | $10.00 | $100,000,000 | - | NYSE | S-1/A | 2026-06-18 | |
| follow-on | amended | - | $0.46 to $1.32 | ~$45,983,294 | Yorkville | OTC | S-1/A | 2026-06-17 | |
| ipo | amended | - | - | - | RH2 Equity Partners | OTCQB | S-1/A | 2026-06-16 | |
| ipo | amended | - | $10.00 | $75,000,000 | EarlyBirdCapital, Inc. | Nasdaq | S-1/A | 2026-06-16 | |
| follow-on | amended | - | - | - | - | NYSE American | S-1/A | 2026-06-15 | |
| ipo | amended | - | $10.00 | $100,000,000 | Kingswood Capital Partners, LLC | Nasdaq | S-1/A | 2026-06-15 | |
| ipo | amended | - | - | - | - | NYSE Arca | S-1/A | 2026-06-12 | |
| ipo | amended | - | - | - | - | - | F-1 | 2026-06-12 | |
| ipo | amended | - | $0.03 | $125,000 | self-underwritten | - | S-1/A | 2026-06-11 | |
|
AZUL SA
AZUL
|
follow-on | amended | - | - | - | - | NYSE American | F-1/A | 2026-06-09 |
| ipo | amended | - | - | - | - | - | F-4/A | 2026-06-09 | |
| ipo | amended | - | $4.00 | $15,000,000 | NETWORK 1 FINANCIAL SECURITIES, INC. | OTC | S-1/A | 2026-06-09 | |
|
Grayscale BNB ETF
GBNB
|
ipo | amended | - | - | - | Seed Capital Investor | Nasdaq | S-1/A | 2026-06-03 |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-06-02 | |
| ipo | amended | - | $10.00 | $125,000,000 | self-underwritten | Nasdaq | S-1/A | 2026-06-01 | |
|
HealthLynked Corp
HLYK
|
follow-on | amended | - | $4.00 | $7,000,000 | Sole Book-Running Manager | OTC | S-1/A | 2026-05-29 |
| ipo | amended | - | $0.02 | $120,000 | self-underwritten | - | S-1/A | 2026-05-28 | |
|
Ealixir, Inc.
EAXR
|
ipo | amended | - | $1.65 to $2.05 | ~$41,814,917 | - | OTC Pink | S-1/A | 2026-05-27 |
| follow-on | amended | - | - | - | - | OTC | F-4 | 2026-05-27 | |
| ipo | amended | - | $10.00 | $150,000,000 | - | Nasdaq | S-1/A | 2026-05-19 | |
| ipo | amended | - | $0.01 | $200,000 | self-underwritten | OTC | S-1/A | 2026-05-15 | |
| ipo | amended | - | $10.00 | $70,000,000 | Berenberg Capital Markets LLC | Nasdaq | S-1/A | 2026-05-12 | |
| ipo | amended | - | - | - | self-underwritten | NYSE Arca | S-1/A | 2026-05-12 | |
| ipo | amended | - | - | - | Seed Capital Investor | Nasdaq | S-1/A | 2026-05-08 | |
| ipo | amended | - | $10.00 | $200,000,000 | self-underwritten | - | S-1/A | 2026-05-05 | |
| ipo | amended | - | $4.00 to $6.00 | ~$18,750,000 | Aegis Capital Corp. | NYSE American | S-1/A | 2026-04-28 | |
| ipo | amended | - | $4.00 to $5.00 | ~$28,125,000 | - | Nasdaq | F-1/A | 2026-04-22 | |
| follow-on | amended | - | - | - | - | - | DRS/A | 2026-04-17 | |
| follow-on trading | amended | - | - | - | Laidlaw & Company (UK) Ltd. | NYSE American | S-1/A | 2026-04-14 | |
| ipo | amended | - | $5.00 | $15,000,000 | D. Boral Capital | NYSE American | S-11/A | 2026-04-14 | |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-04-06 | |
|
INNOCAN PHARMA Corp
INNP
|
ipo | amended | - | $5.50 | ~$20,625,000 | ThinkEquity | NYSE American | FWP | 2026-04-03 |
| ipo | amended | - | $10.00 | - | - | Nasdaq | S-1/A | 2026-04-02 | |
| ipo | amended | - | - | - | - | NYSE Arca | S-1/A | 2026-04-02 | |
| follow-on | amended | - | $8.98 | - | ThinkEquity | OTC | S-1/A | 2026-04-02 | |
| follow-on | amended | - | $4.13 | $10,000,000 | Titan Partners Group | Nasdaq Capital Market | S-1/A | 2026-04-01 | |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-03-31 | |
| ipo | amended | - | - | - | Initial Purchaser | Cboe BZX | S-1/A | 2026-03-31 | |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-03-31 | |
| ipo | amended | - | $10.00 | - | - | Nasdaq | S-1/A | 2026-03-31 | |
| ipo | amended | - | $10.00 | $100,000,000 | - | Nasdaq | S-1/A | 2026-03-30 | |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-03-25 | |
| ipo | amended | - | $10.00 | $250,000,000 | Clear Street LLC | Nasdaq | S-1/A | 2026-03-23 | |
| ipo | amended | - | - | - | - | - | DRS/A | 2026-03-23 | |
|
Medical 21, Inc.
MAVG
|
ipo | amended | - | $10.00 to $12.00 | ~$24,999,997 | ThinkEquity | - | S-1/A | 2026-03-20 |